RWP
GILD icon

Revolve Wealth Partners’s Gilead Sciences GILD Stock Holding History

Revolve Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$691K Buy
5,473
+1,880
+52% +$248K 0.07% 156
2026
Q1 		$501K Buy
3,593
+19
+0.5% +$2.66K 0.07% 130
2025
Q4 		$439K Buy
3,574
+5
+0.1% +$608 0.05% 147
2025
Q3 		$396K Sell
3,569
-26
-0.7% -$2.96K 0.05% 147
2025
Q2 		$399K Buy
3,595
+108
+3% +$11.5K 0.05% 141
2025
Q1 		$391K Buy
3,487
+196
+6% +$20.2K 0.06% 140
2024
Q4 		$304K Buy
3,291
+37
+1% +$3.33K 0.04% 166
2024
Q3 		$273K Sell
3,254
-56
-2% -$4.27K 0.04% 160
2024
Q2 		$227K Sell
3,310
-195
-6% -$13K 0.04% 158
2024
Q1 		$257K Sell
3,505
-102
-3% -$7.84K 0.04% 148
2023
Q4 		$292K Buy
3,607
+130
+4% +$10.1K 0.06% 125
2023
Q3 		$261K Buy
3,477
+192
+6% +$14.8K 0.06% 125
2023
Q2 		$253K Sell
3,285
-72
-2% -$5.74K 0.06% 122
2023
Q1 		$279K Sell
3,357
-236
-7% -$19.5K 0.07% 115
2022
Q4 		$308K Buy
3,593
+245
+7% +$19.4K 0.09% 104
2022
Q3 		$207K Buy
+3,348
New +$211K 0.07% 119
2022
Q1 		– Sell
-3,156
Closed -$229K – 153
2021
Q4 		$229K Buy
+3,156
New +$217K 0.07% 133

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Revolve Wealth Partners's GILD Position: Q2 2026 in Review

Revolve Wealth Partners increased its Gilead Sciences (GILD) stake by 52% in Q2 2026, buying an estimated $248K and bringing the position to 5,473 shares worth $691K. The position accounts for 0.07% of the portfolio, ranked #156.

Revolve Wealth Partners first reported a position in GILD in Q4 2021 and has held it in 17 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Revolve Wealth Partners held 5,473 shares of Gilead Sciences worth $691K as of Q2 2026.
  • Revolve Wealth Partners bought 1,880 Gilead Sciences shares in Q2 2026, an estimated $248K.
  • Gilead Sciences made up 0.07% of Revolve Wealth Partners's portfolio in Q2 2026, its #156 holding.
  • Revolve Wealth Partners first reported a position in Gilead Sciences in Q4 2021 and has held it in 17 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Revolve Wealth Partners's 13F filing for Q2 2026, filed 9 Jul 2026.